3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
38
Colorectal Neoplasms
18
Stomach Neoplasms
7
Biliary Tract Neoplasms
5
Rectal Neoplasms
3
Neoplasm Metastasis
3
Cholangiocarcinoma
3
Neoplasms
2
Metastatic Pancreatic Adenocarcinoma
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Wilms Tumor
1
Weight Loss
1
Triple Negative Breast Neoplasms
1
Small Bowel Adenocarcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Rectal Cancer Patients
1
Pseudomyxoma Peritonei
1
Peritoneal Neoplasms
1
Pancreatic cancer, adult
1
Pancreatic Ductal Adenocarcinoma
1
Pancreatic Diseases
1
Pancreatic Cancer Non-resectable
1
Pancreatic Cancer Metastatic to Liver
1
Pancreatic Adenocarcinoma
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Interventions
Octreotide
3
remune
1
irinotecan sucrosofate
1
bermekimab
1
anamorelin
1
Urine Specimen Collection
1
Psychology, Positive
1
Olanzapine
1
Methods
1
Melatonin
1
Megestrol Acetate
1
Fluorouracil
1
Exercise
1
Enteral Nutrition
1
Endoscopy, Digestive System
1
Diet Therapy
1
Diet
1
Caloric Restriction
1
Blood Specimen Collection
1
Biopsy
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Weight Loss
×
irinotecan sucrosofate
×
Gastrointestinal
×
Clear all
NCT03207724
2020-12-30
OnFX
Cedars-Sinai Medical Center
Phase 1
Completed
16 enrolled